OBJECTIVES To investigate whether gait apraxia is a possible cause for some of the walking abnormalities shown by patients with Alzheimer's disease. METHODS 60 patients with Alzheimer's disease, selected as being free from overt extrapyramidal impairment or other potential causes of walking deficits, were assessed with a new test evaluating aspects of walking and related movements. Norms for ...

Background Context: Walking limitations caused by neurogenic claudication (NC) are typically assessed with self-reported measures, though objective evaluation of walking utilizing motorized treadmill test (MTT) or self-paced walking tests (SPWT) have periodically appeared in the lumbar spinal stenosis (LSS) literature. Purpose: This study compared the validity and responsiveness of MTT and SPWT...

BACKGROUND Executive function impairment (in particular, mental flexibility) in the elderly, and in patients with mild cognitive impairment (MCI), is strongly correlated with difficulties in performing complex walking tasks. The aim of this study was to determine if the adaptation of a neuropsychological test (the Trail-Making Test), to evaluate executive functions during walking, can be an ear...

Objective: To assess prospectively the effect of cardiac resynchronisation therapy (CRT) on New York Heart Association (NYHA) functional class, cardiac function, cardiopulmonary exercise performance, and neurohormonal activation during 24 months’ follow up. Design: Controlled study. Patients and Results: 124 patients with severe congestive heart failure (ejection fraction, 35%, NYHA III– IV) an...

Background—The maximal walking distance (MWD) performed on a treadmill test remains the “gold standard” in estimating the walking capacity of patients who have peripheral arterial disease with intermittent claudication, although treadmills are not accessible to most physicians. We hypothesized that global positioning system (GPS) recordings could monitor community-based outdoor walking and prov...

BACKGROUND The maximal walking distance (MWD) performed on a treadmill test remains the "gold standard" in estimating the walking capacity of patients who have peripheral arterial disease with intermittent claudication, although treadmills are not accessible to most physicians. We hypothesized that global positioning system (GPS) recordings could monitor community-based outdoor walking and prov...

BACKGROUND This study aimed to develop a reliable instrument, the Dogs and Physical Activity (DAPA) tool, for measuring important attributes and scales relating to the dog-walking behavior of dog owners. METHODS Items measuring dog-specific individual, social environmental, physical environmental, and policy-related factors that affect dog owners' walking with their dogs were assessed for tes...

OBJECTIVE To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS The sample included 133 intermittent claudication patients of both genders aged between 30 and 80 years. Data regarding clinical characteristics, the walking impairment questionnaire and treadmill walking te...

[Purpose] This study aimed to determine which clinical measures of walking performance and lower limb muscle strength would predict energy cost during stair ascent and descent in community-dwelling individuals with stroke. [Subjects and Methods] Regression analysis of cross-sectional data from 55 individuals between one and five years post-stroke was used to investigate the measures of walking ...